COLL FY 2020 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$310M+4.5% YoY

Gross Profit

$180M58.0% margin

Operating Income

$56M18.1% margin

Net Income

$27M8.6% margin

EPS (Diluted)

$0.76

Cash Flow

Operating Cash Flow

$94M

Free Cash Flow

-$280M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$644M

Total Liabilities

$458M

Stockholders' Equity

$186M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$310M	$297M	+4.5%
Gross Profit	$180M	$103M	+74.5%
Operating Income	$56M	-$24M	+336.8%
Net Income	$27M	-$23M	+217.7%